Bank of Montreal’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $95.8K | Sell |
23,034
-40,255
| -64% | -$169K | ﹤0.01% | 3247 |
|
|
2026
Q1 | $263K | Sell |
63,289
-1,408
| -2% | -$5.71K | ﹤0.01% | 2764 |
|
|
2025
Q4 | $418K | Buy |
64,697
+45,645
| +240% | +$284K | ﹤0.01% | 2401 |
|
|
2025
Q3 | $107K | Sell |
19,052
-1,000
| -5% | -$4.32K | ﹤0.01% | 2953 |
|
|
2025
Q2 | $66.4K | Buy |
20,052
+4,752
| +31% | +$13.6K | ﹤0.01% | 3085 |
|
|
2025
Q1 | $44.4K | Sell |
15,300
-39,000
| -72% | -$118K | ﹤0.01% | 3091 |
|
|
2024
Q4 | $193K | Buy |
54,300
+4,999
| +10% | +$23.1K | ﹤0.01% | 2776 |
|
|
2024
Q3 | $233K | Buy |
49,301
+35,001
| +245% | +$136K | ﹤0.01% | 2947 |
|
|
2024
Q2 | $38K | Hold |
14,300
| – | – | ﹤0.01% | 3471 |
|
|
2024
Q1 | $62.2K | Sell |
14,300
-4,430
| -24% | -$14.7K | ﹤0.01% | 3406 |
|
|
2023
Q4 | $38.6K | Sell |
18,730
-500
| -3% | -$884 | ﹤0.01% | 3621 |
|
|
2023
Q3 | $32.5K | Hold |
19,230
| – | – | ﹤0.01% | 3504 |
|
|
2023
Q2 | $42.1K | Hold |
19,230
| – | – | ﹤0.01% | 3629 |
|
|
2023
Q1 | $22.1K | Sell |
19,230
-1,500
| -7% | -$1.3K | ﹤0.01% | 3509 |
|
|
2022
Q4 | $18.7K | Buy |
20,730
+3,000
| +17% | +$2.82K | ﹤0.01% | 3708 |
|
|
2022
Q3 | $21 | Buy |
17,730
+531
| +3% | +$600 | ﹤0.01% | 3788 |
|
|
2022
Q2 | $15 | Buy |
17,199
+5,420
| +46% | +$7.21K | ﹤0.01% | 3802 |
|
|
2022
Q1 | $34K | Sell |
11,779
-7,021
| -37% | -$20.5K | ﹤0.01% | 3849 |
|
|
2021
Q4 | $75K | Sell |
18,800
-2,920
| -13% | -$14.7K | ﹤0.01% | 3167 |
|
|
2021
Q3 | $96K | Buy |
21,720
+700
| +3% | +$2.74K | ﹤0.01% | 3460 |
|
|
2021
Q2 | $87K | Buy |
21,020
+16,505
| +366% | +$65.9K | ﹤0.01% | 3350 |
|
|
2021
Q1 | $22K | Sell |
4,515
-2,512
| -36% | -$13.4K | ﹤0.01% | 4004 |
|
|
2020
Q4 | $38K | Buy |
7,027
+1,285
| +22% | +$7.7K | ﹤0.01% | 4080 |
|
|
2020
Q3 | $27K | Sell |
5,742
-1,076
| -16% | -$7.03K | ﹤0.01% | 3686 |
|
|
2020
Q2 | $31K | Sell |
6,818
-3,191
| -32% | -$14.7K | ﹤0.01% | 3646 |
|
|
2020
Q1 | $19K | Buy |
10,009
+6,300
| +170% | +$23.9K | ﹤0.01% | 3259 |
|
|
2019
Q4 | $22K | Sell |
3,709
-18,571
| -83% | -$96.6K | ﹤0.01% | 4260 |
|
|
2019
Q3 | $71K | Sell |
22,280
-942
| -4% | -$3.53K | ﹤0.01% | 3464 |
|
|
2019
Q2 | $98K | Sell |
23,222
-2,640
| -10% | -$13.5K | ﹤0.01% | 3344 |
|
|
2019
Q1 | $178K | Sell |
25,862
-94,489
| -79% | -$662K | ﹤0.01% | 2772 |
|
|
2018
Q4 | $758K | Buy |
120,351
+120,302
| +245,514% | +$1.52M | ﹤0.01% | 2003 |
|
|
2018
Q3 | $1K | Buy |
+49
| New | +$808 | ﹤0.01% | 4481 |
|
Other funds holding AQST
BCM
RI
SCM
PBM
WA
Bank of Montreal's AQST Position: Q2 2026 in Review
Bank of Montreal reduced its Aquestive Therapeutics (AQST) stake by 64% in Q2 2026, selling an estimated $169K and leaving 23,034 shares worth $95.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3247.
Bank of Montreal first reported a position in AQST in Q3 2018 and has held it in 32 quarters since. The position peaked at $758K in Q4 2018. 173 funds tracked by Wall St. Rank hold AQST as of Q2 2026.
- Bank of Montreal held 23,034 shares of Aquestive Therapeutics worth $95.8K as of Q2 2026.
- Bank of Montreal sold 40,255 Aquestive Therapeutics shares in Q2 2026, an estimated $169K.
- Aquestive Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3247 holding.
- Bank of Montreal first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 32 quarters since.
- Bank of Montreal's Aquestive Therapeutics position peaked at $758K in Q4 2018.
- 173 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.